Clinical Trial

Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative Colitis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Ulcerative colitis (UC) is one of the two primary forms of inflammatory bowel disease. This condition is characterized by continuous mucosal inflammation that begins in the rectum and extends proximally throughout the colon. Common intestinal symptoms also include rectal bleeding, increased stool frequency, tenesmus, nocturnal bowel movements, and crampy abdominal pain. Acupuncture has been suggested as a potential intervention to alleviate clinical symptoms of UC. This single-center, parallel-group, two-arm, randomized, sham-controlled trial aims to evaluate the effects and safety of acupuncture for UC.
Trial Details
NCT Number NCT06615765
Lead Sponsor Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions Ulcerative Colitis
Enrollment 64 participants
Start Date 2024-11-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-27